Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-56.13	14.26	32.51
Graham Fair Price	13.71	22.02	19.36
PEG	2039.73	0.96	0.04
Price/Book	-13.95	0.27	0.31
Price/Cash Flow	81.50	-5.49	-29.69
Prices/Earnings	-32.64	25.25	37.49
Price/Sales	-23.38	0.49	0.64
Price/FCF	81.50	-5.49	-29.69
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	380.19	0.31	0.07
Operating Margin	-37.24	< 0.005	-0.01
ROA	26.45	< 0.005	< 0.005
ROE	< 0.005	< 0.005	27.75
ROIC	< 0.005	< 0.005	28.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.23	-79.53
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.68	1.70	1.54
EPS QOQ	8.36	0.26	-96.85
FCF QOQ	-1.35	-3.65	-169.90
Revenue QOQ	-0.07	0.12	70.55
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	115.76	139.72	20.70
Days Sales Outstanding (DSO)	61.44	63.49	3.33
Inventory Turnover	0.78	0.64	-17.15
Debt/Capitalization	0.21	0.22	3.73
Quick Ratio	0.77	0.76	-1.29
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	89.24	89.78	0.60
Cash	17.37	13.78	-20.70
Capex	-3.95	-1.76	55.48
Free Cash Flow	-0.94	-4.41	-368.02
Revenue	44.09	49.82	12.99
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.79	1.75	-2.29
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.26	4.62	-26.14
Naive Interpretation	Member

06 - Financial Health · Weak

Rating